Skip navigation
Browsing by Author Yip, S.
Showing results 1 to 3 of 3
| Preview | Issue Date | Title / Name | Author(s) |
| Sep-2020 | Durvalumab with first-line chemotherapy in previously untreated malignant pleural mesothelioma (DREAM): a multicentre, single-arm, phase 2 trial with a safety run-in | Nowak, A.K.; Lesterhuis, W.J.; Cook, A.M.; Kok, P.S.; Brown, C.; Langford, A.; Yip, S.; Stockler, M.R.; Hughes, B.G.; Karikios, D.J.; John, T.; Kao, S.C.H.; Leslie, C.; Pavlakis, N.; Briscoe, Karen; O'Byrne, K.J.; Karapetis, C.S.; Lam, W.S.; Briscoe, Karen | |
| Aug-2021 | MONARCC: a randomised phase II study of panitumumab monotherapy and panitumumab plus 5-fluorouracil as first-line therapy for RAS and BRAF wildtype metastatic colorectal cancer: a study by the Australasian Gastrointestinal Trials Group (AGITG) | Siu, H. W. D.; Tebbutt, N.; Chantrill, L.; Karapetis, C.; Steer, C.; Wilson, K.; Espinoza, D.; Bailey, L.; Yip, S.; Cuff, J.; Pavlakis, N.; Thavaneswaran, S.; Briscoe, K.; Srivastav, R.; Shannon, J.; Segelov, E.; Tie, J.; Caird, S.; Francesconi, A.; Price, T.; Wuttke, M.; Ladwa, R.; Sjoquist, K.; Burge, M.; Briscoe, Karen | |
| Sep-2023 | NUTMEG: A randomized phase II study of nivolumab and temozolomide versus temozolomide alone in newly diagnosed older patients with glioblastoma | Sim, H. W.; Wachsmuth, L.; Barnes, E. H.; Yip, S.; Koh, E. S.; Hall, M.; Jennens, R.; Ashley, D. M.; Verhaak, R. G.; Heimberger, A. B.; Rosenthal, M. A.; Hovey, E. J.; Ellingson, B. M.; Tognela, A.; Gan, H. K.; Wheeler, H.; Back, M.; McDonald, K. L.; Long, A.; Cuff, K.; Begbie, S.; Gedye, C.; Mislang, A.; Le, Hien; Johnson, M. O.; Kong, B. Y.; Simes, J. R.; Lwin, Z.; Khasraw, M.; Begbie, Stephen | |
